Insmed Inc. buy UBS Group AG
Start price
27.02.24
/
50%
€26.80
Target price
27.02.25
€42.39
Performance (%)
144.40%
Price
26.09.24
€65.00
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Insmed Inc. has seen massive gains of 144.40%. This prediction currently runs until 27.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -1.527% | -1.527% |
| iShares Core DAX® | 0.936% | 1.535% |
| iShares Nasdaq 100 | 3.064% | 1.968% |
| iShares Nikkei 225® | 1.898% | -0.295% |
| iShares S&P 500 | 1.653% | 2.318% |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat